Waters acquity uplc system
The Waters Acquity UPLC system is an ultra-performance liquid chromatography (UPLC) instrument designed for high-throughput and high-resolution separation of complex samples. The system utilizes advanced technology to deliver rapid, efficient, and reproducible chromatographic separations. It is capable of operating at high pressures, enabling the use of smaller particle size columns for improved resolution and reduced analysis times.
Lab products found in correlation
131 protocols using waters acquity uplc system
UHPLC-MS/MS Analysis of Compounds
Quantitative Analysis of Cordycepin in GRC-SC11
Metabolomics Analysis of Bioactive Compounds
MS analysis, was coupled to identify the active metabolite based on
their molecular mass as obtained from spectral data. The MS was performed
on a Water’s ACQUITY UPLC (TM) system (Waters Corp., MA, USA)
equipped with a binary solvent delivery system, an auto-sampler, column
manager, and a tunable MS detector operated through Empower software
(Waters, Manchester, UK). For optimum chromatographic separation,
acetonitrile (A) and water (B) were run on a monolithic capillary
silica-based C18 column (ACQUITY UPLC(R) BEH C18 1.7 μm, 2.1
× 100 mm). The flow rate of the nebulizer gas was set at 500
L/h; for cone gas, it was set at 50 L/h, and the source temperature
was fixed at 100 °C. The capillary and cone voltage was set at
3.0 and 40 KV, respectively. For collision, argon was employed at
a pressure of 5.3 × 10–5 torr. The obtained
spectral data from MS was processed by Mass Lynx V4.1 (Waters, USA)
and further used for metabolomics analysis of the samples. Separated
metabolites present in different samples were tentatively identified
based on their m/z values from mass data sources
such as Mass Bank, PubChem, Drug Bank, ChemSpider, and literature.47 (link),49 (link)
Quantification of Tofacitinib in Plasma by UPLC-MS/MS
The plasma concentration of tofacitinib was determined by ultra-performance liquid chromatography (UPLC, Waters ACQUITY UPLCTM System, Waters Co., Milford, MA, USA)-tandem mass spectrometry (MS/MS, Waters XevoTM TQ MS, Waters Co.). Stock standard solution (100 μg/mL of tofacitinib in 50% methanol) was used as a reference standard. The samples were analyzed on a Waters ACQUITY UPLC® BEH C18 column (1.7 μm, 2.1 mm ID × 50 mm L; Waters Co.) using acetonitrile and 0.1% ammonium acetate in distilled water (80:20, v/v) as the mobile phase within 0.4 mL/min.
This method was validated over the concentration range of 0.5–250 ng/mL for tofacitinib. The lower limit of quantitation (LLOQ) was 0.5 ng/mL. The intra- and inter-batch precision (coefficient of variance [CV]) and accuracy ranged from 1.6–6.4 and 97.9–103.0%, respectively. All validation results were in compliance with the EMA Guideline on Bioanalytical Method Validation [16 (link)].
UPLC-MS Analysis of Chemical Compounds
UPLC-MS Analysis of BMAE Constituents
UHPLC-MS Metabolite Profiling Protocol
Optimized UPLC-MS Bioanalytical Method
UPLC-MS/MS Quantification of NBP
UPLC-MS/MS Analysis of Metabolites
The Waters SynaptTM G2-Si MSE mass spectrometry system (Waters Corporation, Milford, MA, USA) was used to collect data in both positive and negative ion modes (ESI+, ESI−). The optimized conditions were as follows: ion source temperature 110 °C, desolvation gas temperature 350 °C, cone gas flow rate 50 L/h. In positive ion detection mode, the capillary voltage was 2.8 kV, the sample cone voltage was 20 V, the extraction cone voltage was 4.0 V, and the desolvation gas flow rate 800 L/h. In the negative ion detection mode, the capillary voltage was 2.2 kV, the sample cone voltage was 40 V, the extraction cone voltage was 4.0 V, and the desolvation gas flow was 600 L/h. Leucine enkephalin solution was used as the mass lock solution. The data acquisition interval was 0.2 s/scan, and the mass scanning range was 50–1200 Da.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!